Ginkgo Bioworks Holdings (DNA) Other Non-Current Assets (2020 - 2026)

Ginkgo Bioworks Holdings posted quarterly Other Non-Current Assets of $3.2 million for Q1 2026, down 93.14% year-on-year from $46.8 million in Q1 2025, and down 93.19% on a QoQ basis from $47.2 million in Q4 2025.

Ginkgo Bioworks Holdings (DNA) has 7 years of Other Non-Current Assets data on file, last reported at $3.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets fell 93.14% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (down 93.14% YoY), and the FY2025 full-year result was $47.2 million, down 14.76% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $3.2 million, down from $47.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $97.9 million in Q2 2023 and bottomed at $3.2 million in Q1 2026.
  • The 5-year median for Other Non-Current Assets is $55.3 million (2024), against an average of $59.5 million.
  • The widest annual swing landed in 2023, when Other Non-Current Assets soared 120.87%; it then sank 93.14% in 2026.
  • A 5-year view of Other Non-Current Assets shows it stood at $88.7 million in 2022, then plunged by 34.57% to $58.1 million in 2023, then decreased by 4.68% to $55.3 million in 2024, then slipped by 14.76% to $47.2 million in 2025, then sank by 93.19% to $3.2 million in 2026.
  • The last three Other Non-Current Assets figures came in at $3.2 million (Q1 2026), $47.2 million (Q4 2025), and $46.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 12.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 60,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.26 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.13 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 63.55 Mn
10 Ginkgo Bioworks Holdings 542.03 Mn 542.03 Mn 16.38 Mn 3.21 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.21 Mn
Dec 31, 2025 47.17 Mn
Sep 30, 2025 46.59 Mn
Jun 30, 2025 47.02 Mn
Mar 31, 2025 46.78 Mn
Dec 31, 2024 55.34 Mn
Sep 30, 2024 59.79 Mn
Jun 30, 2024 60.21 Mn
Mar 31, 2024 60.63 Mn
Dec 31, 2023 58.06 Mn
Sep 30, 2023 97.02 Mn
Jun 30, 2023 97.95 Mn
Mar 31, 2023 97.26 Mn
Dec 31, 2022 88.73 Mn
Sep 30, 2022 43.93 Mn
Jun 30, 2022 53.02 Mn
Mar 31, 2022 49.62 Mn
Dec 31, 2021 43.99 Mn
Sep 30, 2021 26.80 Mn
Dec 31, 2020 5.60 Mn